Key result
PTEN and HSPA5 are upregulated while CRIP1 is downregulated in CAD and metabolic syndrome.
Why the study?
What are the shared programmed cell death-related hub genes and potential targeting compounds in patients with coronary artery disease complicated by metabolic syndrome?
What are the shared programmed cell death-related hub genes and potential targeting compounds in patients with coronary artery disease complicated by metabolic syndrome?
Answers are grounded in this paper and cite their sources.
Integrative bioinformatics and preliminary RT-qPCR validation identify PTEN, HSPA5, and CRIP1 as shared programmed cell death-related biomarkers for comorbid CAD and metabolic syndrome, with quercetin predicted in silico as a potential targeting compound.
Given the high comorbidity and shared pathological mechanisms between coronary artery disease (CAD) and metabolic syndrome (MetS), this study aimed to identify and validate key programmed cell death (PCD)-related hub genes common to both conditions and to assess their therapeutic potential. Differentially expressed genes (DEGs) were identified from Gene Expression Omnibus (GEO) datasets and intersected with PCD-related genes to obtain candidate genes. Hub genes were screened using machine learning algorithms, and their diagnostic value, functional pathways, immune correlations, and regulatory networks were systematically evaluated through bioinformatics analyses. Potential herb-derived compounds were predicted via network pharmacology and examined by molecular docking and molecular dynamics simulations, followed by absorption, distribution, metabolism, excretion, and toxicity analysis. Finally, the expression levels of hub genes in clinical samples were detected by RT-qPCR. A total of 37 candidate genes were screened, from which Phosphatase and Tensin Homolog (PTEN), Heat Shock Protein Family A (Hsp70) Member 5 (HSPA5), and Cysteine Rich Protein 1 (CRIP1) were identified as hub genes with high diagnostic value and good nomogram predictive performance. The ssGSEA scores of mast cells differed significantly between CAD/MetS patients and controls. Quercetin was predicted to potentially bind to PTEN and HSPA5 and to have high gastrointestinal absorption. PTEN and HSPA5 were significantly upregulated, and CRIP1 was downregulated in CAD and MetS patients compared with controls, with a more obvious trend in the comorbid group. PTEN, HSPA5, and CRIP1 were potential targets for CAD and MetS, with quercetin as a promising intervening agent.
No takes yet. Share an insight, caveat, or question.
Xia et al. (2026) studied Coronary artery disease complicated by metabolic syndrome (n=84). Programmed cell death-related hub genes (PTEN, HSPA5, CRIP1) and in silico quercetin binding vs. Healthy controls was evaluated on Identification and differential mRNA expression of programmed cell death-related hub genes (PTEN, HSPA5, CRIP1) (p=<0.05). PTEN and HSPA5 were upregulated and CRIP1 was downregulated in coronary artery disease and metabolic syndrome patients compared with controls.
Synapse has enriched 10 related papers. Consider them for comparative context: